Division of Basic Medical Research FY2020 List of Projects - Research Program on HIV/AIDS
| First Year | Final Year | Principal Investigator | Affiliation | Project Title | |
|---|---|---|---|---|---|
| FY2018 | FY2020 | MATANO Tetsuro | National Institute of Infectious Diseases | Director | Study for the development of HIV vaccines inducing functional antibodies |
| FY2018 | FY2020 | SUZU Shinya | Kumamoto University | Professor | Study aiming at the identification and eradication of bona fide HIV reservoirs |
| FY2018 | FY2020 | TACHIKAWA Ai | National Institute of Infectious Diseases | Chief | Research on improvement of immunopathogenesis for HIV cure |
| FY2018 | FY2020 | KOYANAGI Yoshio | Kyoto University | Professor | Analysis of HIV regulome and generation of HIV cure strategy |
| FY2018 | FY2020 | MAEDA Kenji | National Center for Global Health and Medicine | Section Chief | Research on the development of anti-HIV drugs with a novel mechanism of action to cure HIV |
| FY2018 | FY2020 | TERUYA Katsuji | National Center for Global Health and Medicine | Chief Physician | Study on appropriate management of opportunistic illnesses in the era of early and prolonged ART |
| FY2018 | FY2020 | OHMORI Tsukasa | Jichi Medical University | Professor | A study to create new generation treatments and diagnosis for cure of hemophilia as an HIV-related disorder |
| FY2018 | FY2020 | NOYORI Osamu | Kumamoto University | Postdoctoral researcher | Study of a novel route of intercellular HIV spread |
| FY2018 | FY2020 | SATO Kei | The University of Tokyo | Associate Professor | Investigation of synergistic/contrary anti-HIV-1 responses mediated by innate, intrinsic and acquired immunity |
| FY2018 | FY2020 | MIYAKAWA Kei | Yokohama City University School of Medicine | Senior Lecturer | Development of spatiotemporal analysis for HIV spread |
| FY2018 | FY2020 | KUSE Nozomi | Kumamoto University | Specially Appointed Associate Professor | Induction of HIV-1-specific CD8+ T cells with super-function from naïve T cells |
| FY2018 | FY2020 | YAMAMOTO Hiroyuki | National Institute of Infectious Diseases | Chief (Group leader) | Analysis of virus-specific B-cell responses as a platform of prophylactic and therapeutic HIV neutralizing antibody induction |
| FY2019 | FY2021 | SATOU Yorifumi | Kumamoto University | Professor | Creation of new druggable targets to overcome HIV-1 latency via collaboration between high-resolution nucleic acid analyses and leading-edge techniques for viral dynamics |
| FY2019 | FY2021 | NOMURA Takushi | National Institute of Infectious Diseases | Senior Researcher | Study for eradication of latently infected cells in SIV controllers |
| FY2019 | FY2021 | MATSUSHITA Shuzo | Kumamoto University | Professor | Neutralizing antibody-mediated treatment strategy towards cure of HIV-1infection |
| FY2019 | FY2021 | MONDE Kazuaki | Kumamoto University | Assistant Professor | Construction of drug screening system against HIV-1 Gag proteins |
| FY2019 | FY2021 | KOTANI Osamu | National Institute of Infectious Diseases | Senior Researcher | Creation of a groundbreaking platform for structural biology to promote novel studies of HIV replication and drug discovery |
| FY2019 | FY2021 | KIKUCHI Tadashi | National Institute of Infectious Diseases | Senior Researcher | Study of long-term trend of circulating HIV strains and HIV drug resistance in Japan |
| FY2019 | FY2020 | SHIINO Teiichiro | National Institute of Infectious Diseases | Senior Researcher | Study for system development of HIV and the host genome database construction and publication |
| FY2019 | FY2021 | KIMURA Kiminori | Tokyo Metropolitan Komagome Hospital | Director | Development of anti-fibrotic drugs for liver cirrhosis caused by HIV / HCV co-infection combined with hemophilia |
| FY2019 | FY2021 | ISHII Hiroshi | National Institute of Infectious Diseases | Researcher | Determination of vaccine-induced immune responses accelerating HIV replication |
| FY2019 | FY2021 | CHIKATA Takayuki | Kumamoto University | Specially Appointed Associate Professor | Use of LC-MS/MS for identification of T cell with effective function for HIV eradication |
| FY2020 | FY2022 | AKARI Hirofumi | Kyoto University | Professor | Evaluation in the efficacy of HIV cure therapeutics by the non-human primate model of HIV infection |
| FY2020 | FY2022 | TAKAORI Akifumi | Kyoto University | Professor | Development of novel immunotherapy against HIV-1 infection using alpaca VHH technology |
Last updated 04/12/21